申请人:Teijin Pharma Limited
公开号:US10689354B2
公开(公告)日:2020-06-23
A compound, represented by the following formula or a medically acceptable salt thereof, having an effect of regulating the activity of an androgen receptor. In the formula, X represents S, O; Z represents (Ra)n-A-(CR13R14)0-1—(CR11R12)0-1; A represents aryl, heteroaryl; R1 represents alkyl, cycloalkyl, alkenyl, alkynyl, alkoxyalkyl, aryl, arylalkyl, heterocycle, heterocyclic alkyl; R2 represents hydrogen, halogen, alkyl, cycloalkyl, phenyl; R3 represents hydrogen, halogen, alkyl, cycloalkyl, alkoxyalkyl, alkenyl, alkynyl, cycloalkenyl, aryl, arylalkyl, heterocycle, heterocyclic alkyl, acyl, cycloalkylcarbonyl, benzoyl, spiroalkyl, adamantyl, silyl, R31R32NCO—; R4 and R5 represent hydrogen, halogen, alkyl, phenyl, and cycloalkyl.
一种由下式代表的化合物或其医学上可接受的盐,具有调节雄激素受体活性的作用。式中,X代表S、O;Z代表(Ra)n-A-(CR13R14)0-1-(CR11R12)0-1;A代表芳基、杂芳基;R1代表烷基、环烷基、烯基、炔基、烷氧基烷基、芳基、芳烷基、杂环、杂环烷基;R2代表氢、卤素、烷基、环烷基、苯基;R3 代表氢、卤素、烷基、环烷基、烷氧基烷基、烯基、炔基、环烯基、芳基、芳烷基、杂环、杂环烷基、酰基、环烷基羰基、苯甲酰基、螺烷基、金刚烷基、硅烷基、R31R32NCO-;R4 和 R5 代表氢、卤素、烷基、苯基和环烷基。